Gastro Broadcast

Gastro Broadcast
  • 5.0（4則評分）
  • 醫學
  • 每月更新
Gastro Broadcast

Independent GI physicians and administrative leaders discuss issues that impact gastroenterology.

  1. 11月13日

    Episode #67: Understanding Nutritional Strategies for IBD | Naresh Gunaratnam, Kim Beall & Ashwin Ananthakrishnan

    Dr. Naresh Gunaratnam interviews Kim Beall, co-founder and managing director of Nutritional Therapy for IBD and Dr. Ashwin Ananthakrishnan, who is the Director of the Massachusetts General Hospital Crohn's and Colitis Center about their work to advance evidence-based nutrition as part of IBD treatment plans. When nutritional strategies are used in combination with medications, additional pathways are engaged to improve symptoms, quality of life and aid tissue healing. When patients are able to access evidence-based nutritional therapy under the guidance of a healthcare providers it can them find foods to restore a healthy relationship with food and work their way back to a well-balanced diet of healthy, foods while at the same time feeling well again. Join Dr. Gunaratnam, Ms. Beall and Dr. Ananthakrishnan as they explore how Nutritional Therapy for IBD works to inform, support, and empower patients and clinicians by providing education and essential tools and resources to utilize nutritional therapy alongside medication.

    30 分鐘

  2. 10月23日

    Episode #66: This Colonoscopy Prep Includes Chocolate Chip Cookies |Lisa Mathew & Jeff Scott | Happy Colon Foods

    Dr. Lisa Mathew interviews Dr. Jeff Scott, a gastroenterologist and founder of Happy Colon Foods, a company that prepares meal kits that are compliant with the diet requirements before a colorectal screening. Happy Colon Foods is designed to mimic a typical day, with three meals and snacks in between, including mac n' cheese and cookies. Because smaller doses of laxatives are spread throughout the day, many patients can work either part or most of their prep day. A large, randomized trial published in 2013 compared the results of clear-liquid only and low-residue diets, and found that a low-residue diet, is just as effective than a diet restricted to clear liquids. Join Dr. Mathew and Dr. Scott as they explore how this type of colonoscopy prep can remove some of the difficulty of preparing for a colonoscopy and encourage people to get screened. - Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 66, presented by TissueCypher from Castle Biosciences

    26 分鐘

  3. 10月9日

    Episode #65: Identifying High-Risk Barrett’s Esophagus Patients | Lisa Mathew & Raman Muthusamy | UCLA School of Medicine

    Dr. Lisa Mathew interviews Dr. Raman Muthusamy, professor of clinical medicine at the David Geffen School of Medicine at UCLA, and medical director of endoscopy for UCLA Health, about a new clinical guideline for endoscopic eradication therapy to prevent the progression of Barrett’s esophagus to esophageal cancer. Esophageal cancer is preventable if high-risk patients, such as those with Barrett’s Esophagus, are treated with endoscopic eradication therapy to eliminate the Barrett’s tissue. Endoscopic eradication therapy is highly effective, but the challenge is identifying the high-risk patients to treat and the low-risk patients for whom long-interval surveillance may be appropriate. Join Dr. Mathew and Dr. Muthusamy as they explore new technologies for identifying patients who are most at risk and the potential innovations that could stop a majority of Barrett’s Esophagus patients from progressing to esophageal cancer. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 65, presented by TissueCypher from Castle Biosciences

    17 分鐘

  4. 9月24日

    Episode #64: Pros & Cons of New Blood Test for Colorectal Cancer | Fred Rosenberg & Lauren Bleich | Gastro Health

    Dr. Fred Rosenberg interviews Dr. Lauren Bleich, of Gastro Health, who serves as president of the Massachusetts Gastroenterology Society about a new blood-based screening test from Guardant Health for colorectal cancer. This summer, a U.S. Food & Drug Administration advisory panel voted that the Shield test was safe and effective, after reviewing evidence from a study which showed that the test correctly detected colorectal cancer in 83% of people confirmed to have it. However, the panel cautioned that while the test is effective in finding later-stage cancers, it only detected 13% of earlier-stage polyps. Join Dr. Rosenberg and Dr. Bleich as they discuss the opportunities and limitations of this new test in detecting polyps, and why colonoscopy remains the gold standard for colorectal cancer screening, as the only test that prevents colon cancer by removing polyps before they can turn into cancer. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 64, presented by TissueCypher from Castle Biosciences

  5. 9月10日

    Episode #63: Despite ACA Mandate Most Patients Pay for Bowel Prep | Michael Weinstein & Eric Shah | University of Michigan

    Dr. Michael Weinstein interviews Dr. Eric Shah, director of the Michigan Medicine GI Physiology Laboratories about a study showing that despite a federal law that says bowel preparations needed for colonoscopy should be covered by insurance, many patients are still paying out of pocket. The study, from the University of Michigan Health, analyzed nearly 2.6 million insurance claims from both commercial insurance plans and Medicare Part D, and looked at how many patients paid for bowel prep medications needed for colonoscopy. The Affordable Care Act (ACA) requires that certain preventative services, including colorectal cancer screening, must be covered by insurance plans without cost-sharing for patients. Unfortunately, prescription bowel prep for screening colonoscopy is still subject to cost sharing for most patients, running contrary to the ACA's mandate. When considering that nearly half of patients are cost-shifted toward the use of non-FDA approved over-the-counter regimens, the data suggest that only 17 percent of patients pay zero for their bowel preparation for screening colonoscopy. Of the prescription claims analyzed, only 36 percent had no out-of-pocket costs. Additionally, high-volume preps were more likely to be free compared to new, low-volume or tablet preparations. However, when patients did pay, high-volume preps cost a median of $10, while low-volume preps cost $60. For Medicare Part D, only 25 percent of high-volume preps were free, compared to 10 percent for low-volume preps. Join Dr. Weinstein and Dr. Eric Shah as they discuss how these co-pays for bowel prep can impact patients and what private practice gastroenterologists can do to educate their communities and to engage in advocacy so that co-pays do not present a barrier to colorectal cancer screening. Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 63, presented by TissueCypher from Castle Biosciences

    20 分鐘

  6. 7月10日

    Episode #62: Data-Driven Solutions to Improve Healthcare Delivery | Lisa Mathew & Mitesh Rao | OMNY Health

    Dr. Lisa Mathew interviews Dr. Mitesh Rao, chief executive officer of OMNY Health, about the organization's work to connect the healthcare ecosystem through data and insights to transform healthcare delivery, improve clinical outcomes, and address patients’ unmet needs.  OMNY Health recently announced a partnership with several of the nation's leading GI practices to enable insights on patient population characteristics, care delivery patterns, and treatment outcomes based on data extracted from de-identified electronic health records (EHRs). The partnership will provide valuable information on disease severity, rationale behind treatment decisions, treatment efficacy, and impact of social determinants on treatment selection and disease progression. Listen to Dr. Mathew and Dr. Rao as they explore how independent GI practices can be connected with research and development efforts underway in gastroenterology, including Crohn's & Colitis, celiac disease, short bowel syndrome, and many others. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 62, presented by TissueCypher from Castle Biosciences

    24 分鐘

  7. 6月25日

    Episode #61: SonarMD Reduces ER Visits for IBD Patients (and how GI practices should be thinking about value-based care)

    Kevin Harlen interviews Dr. Larry Kosinski, chief medical officer for SonarMD, a remote monitoring and care coordination program for chronic conditions like Inflammatory Bowel Disease. SonarMD recently announce positive results from two large, longitudinal studies evaluating several major drivers of medical costs in people living with Inflammatory Bowel Disease (IBD) and enrolled in the company’s end-to-end, digital care coordination program. In both studies, SonarMD participants experienced a statistically significant and substantial decline in Emergency Department visits and In-patient Admissions compared to risk-matched control groups. Join Kevin and Dr. Kosiniski as they discuss the future of GI and new innovations that can help practices implement value-based care programs for their patients. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 61 presented by TissueCypher from Castle Biosciences

    29 分鐘

  8. 6月11日

    Episode #60: Enhancing Polyp Detection Using AI (ModMed is collaborating with Medtronic to help GI docs find more polyps)

    Dr. Fred Rosenberg interviews Dr. Jason Sugar from Washington Gastroenterology, who also serves as the gastroenterology team lead at Modernizing Medicine (ModMed). ModMed recently announced a collaboration with Medtronic to enhance the documentation of polyp detection by utilizing the AI capabilities its GI Genius system. The GI Genius system enables AI-assisted colonoscopies, which have been shown to achieve a 50% reduction in missed colorectal polyps over a standard colonoscopy. The companies intend to interface data from GI Genius into ModMed’s gGastro platform with the expectation of reducing manual effort in documenting procedural metrics captured during the colonoscopy process. Join Dr. Rosenberg and Dr. Sugar to hear about this collaboration and how ModMed is helping GI practices grow and scale by delivering better patient experiences with intelligent software solutions. --- Produced by Andrew Sousa and Hayden Margolis for Steadfast Collaborative, LLC Mixed and mastered by Hayden Margolis Gastro Broadcast, Episode 60, presented by TissueCypher from Castle Biosciences

    15 分鐘
顯示全部 (67)

評分與評論

5
（滿分 5 顆星）
4 則評分

簡介

Independent GI physicians and administrative leaders discuss issues that impact gastroenterology.

資訊

  • 創作者
    Gastro Broadcast
  • 活躍年代
    2021年 - 2024年
  • 集數
    67
  • 年齡分級
    兒少適宜
  • 版權
    © The entire content and design of Gastro Broadcast are the property of Steadfast Collaborative, LLC and are protected under United States and international copyright and trademark laws.
  • 節目網站
    Gastro Broadcast

你可能也會喜歡

若要收聽兒少不宜的單集，請登入帳號。

隨時掌握此節目最新消息

登入或註冊後，即可追蹤節目、儲存單集和掌握最新資訊。
選取國家或地區

非洲、中東和印度

亞太地區

歐洲

拉丁美洲與加勒比海地區

美國與加拿大